Riyadh, September 24, 2023, King Saud Medical City (KSMC), specifically through its Heart Health Center, has reached a significant medical milestone by successfully utilizing Supersaturated Oxygen (SSO2) Therapy to treat a patient who suffered an acute heart attack in the anterior left artery. This achievement stands as a pioneering accomplishment in the Middle East and North Africa.
KSMC detailed that this cutting-edge technology plays a pivotal role in safeguarding heart muscle cells from damage in the aftermath of an acute heart attack. Importantly, it has received scientific validation and regulatory approval from both the Saudi Food and Drug Authority (SFDA) and the American Food and Drug Administration (FDA).
The medical institution stressed that the patient is presently in stable health and is expected to be discharged shortly, highlighting the effectiveness of SSO2 Therapy in improving patient outcomes.
